QQ客服 官方微博 反馈留言

	Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway
	Li, Hongbo; Wang, Zhenkai; Zhang, Jie; Wang, Youlei; Yu, Chen; Zhang, Jinjin; Song, Xiaodong; Lv, Changjun
刊名	BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE
	2018
卷号	18
关键词	Pulmonary fibrosis Feifukang Traditional Chinese medicine
DOI	10.1186/s12906-018-2297-3
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4569714
专题	山东大学
作者单位	1.Shandong Univ, Sch Med, Dept Pulm Med, Jinan 250100, Shandong, Peoples R China. 2.[Li, Hongbo 3.Wang, Zhenkai 4.Lv, Changjun
推荐引用方式 GB/T 7714	Li, Hongbo,Wang, Zhenkai,Zhang, Jie,et al. Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway[J]. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE,2018,18.
APA	Li, Hongbo.,Wang, Zhenkai.,Zhang, Jie.,Wang, Youlei.,Yu, Chen.,...&Lv, Changjun.(2018).Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway.BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE,18.
MLA	Li, Hongbo,et al."Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway".BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE 18(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。